You are about to leave the Clinical Value website now.

Cancel

Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study

Quick Summary

This study systematically evaluates biomarkers mentioned in international guidelines and peer-reviewed literature for HCC surveillance and diagnosis, in order to identify combinations of biomarkers that display high sensitivity and specificity for early stage HCC detection.

You May Also Like

12 February 2026

LEAD Perspective: Evaluating GAAD – A Malaysian Multicentre Study

Read More
12 February 2026

LEAD Perspective: The Taiwan Liver Story – Hepatitis Elimination and HCC Surveillance

Read More
12 February 2026

LEAD Perspective: Asia Pacific Consensus Statement on the clinical and economic utility of biomarker-based algorithms in the early detection and surveillance of HCC

Read More

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.